The Market Institute has joined the Center for a Free Economy and more than three dozen national organizations in urging Congress to pass the USTRx Act (H.R. 4780), legislation that would help end the unfair practice of foreign governments shifting the cost of pharmaceutical innovation onto American patients. In a Read more…
The healthcare system is often described as broken, but as Charles Sauer explained during a recent event hosted by the Mises Institute, the solutions already exist. The challenge is not creating better models of care—it’s removing the government policies that prevent them from flourishing. Recorded on June 27 in Windham, Read more…
A newly published paper in The Milbank Quarterly adds to the growing body of evidence that the federal 340B Drug Pricing Program has strayed far from its original purpose, strengthening the case for meaningful congressional reform. In a recent RealClearMarkets commentary, Market Institute Senior Fellow Norm Singleton highlights Stretching Scarce Read more…
A new RealClearHealth op-ed by Dr. Craig Wax argues that if Congress is serious about reducing healthcare costs and increasing competition, lawmakers must reform one of the federal government’s biggest distortions: Medicare’s unequal payment system. Dr. Wax explains how current Medicare policy allows hospital systems to charge significantly more than Read more…
Innovation has been central to America’s economic success since the nation’s founding. In a new column for RealClearMarkets, Market Institute President Charles Sauer argues that policymakers should remember the vital role patents have played in driving growth, investment, and technological advancement. Sauer traces the history of patents from the earliest Read more…
Market Institute President Charles Sauer joined the Scott Sloan Show on 700 WLW to discuss the need for Medicare Advantage reform as policymakers focus on reducing waste, fraud, and abuse in federal healthcare programs. During the conversation, Sauer explained how Medicare Advantage provides valuable choices for seniors but also contains Read more…
Market Institute President Charles Sauer warns in a new Washington Examiner op-ed that proposals to impose Section 232 tariffs on medical devices would ultimately increase healthcare costs for Americans while doing little to strengthen an industry the United States already leads. As the Trump administration considers whether to expand tariffs Read more…
Listen Here Market Institute President Charles Sauer joined Lars Larson on “The Lars Larson Show” to discuss why Alzheimer’s policy could become a defining issue in the upcoming election cycle — especially in key swing states. The conversation focused on new polling data, early diagnosis, access to treatment, and the Read more…
A new op-ed by Charles Sauer in the Washington Times argues that earlier Alzheimer’s diagnosis is not only a healthcare issue, but also a financial one for millions of American families. In the piece, Sauer explains how cognitive decline often begins affecting financial decision-making years before a formal diagnosis, leaving Read more…
In a recent piece for the Daily Caller, Charles Sauer highlights a growing disconnect between medical innovation and public policy when it comes to Alzheimer’s care—and the consequences could not be more serious. Health and Human Services Secretary Robert F. Kennedy Jr. recently put it plainly: “it is regulatory malpractice Read more…